Mobile But Still Tied Down: Challenges to Scaling Mobile Methadone Through a Regulatory Thicket

Krawczyk N, Miller M, Frank D, Harris SJ, O'Rourke A, Song M, Ruelas-Vargas K, Gibbons JB, Jordan A, Saloner B - International Journal of Drug Policy

  • Price, Value, and Access

Summary:

Using New York’s early rollout as a case study, the authors describe how mobile methadone units remain hamstrung by security rules, high costs, requirements to return daily to a home clinic and stay within state lines, and community opposition. The authors argue that without a broader shift away from “methadone exceptionalism,” mobile units will remain a modest convenience rather than a transformative way to close treatment gaps.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access